Literature DB >> 12778854

[Biochemical and histological spectrum of renal osteodystrophy in Argentina].

W G Douthat1, G Garay, J de Arteaga, J L Fernández Martín, J B Cannata Andía, P U Massari.   

Abstract

Between 1994-2001 we have performed 57 bone biopsies for diagnostic purposes in symptomatic CRF patients. We analyzed here 52 samples where the material was optimal for study, and divided them into 2 periods according to when the biopsy was performed: 1994-1996 and 1997-2001, to verify changes in the spectrum of renal osteodystrophy. Mean serum values were: serum calcium 9.9 +/- 1.8 mg/dl, phosphate 5.8 +/- 3.2 mg/dl, alkaline phosphatase 693.9 +/- 968.9 Ul/L, iPTH 562.0 +/- 598.5 pg/ml, serum aluminum 65.7 +/- 79.3 ug/L and bone aluminum 22.8 +/- 22.4 ug/g. Hyperparathyroidism was the most common histological diagnosis as severe in 13 patients (25%), or as mild in 14 (27%). Ten patients had osteomalacia (19%), adynamic bone disease was diagnosed in 5 (9.6%) and mixed renal osteodystrophy in 10 (19.2%). Low bone turnover patients showed higher bone and serum aluminum than high bone turnover patients. We observed a relative increment in high turnover bone disease in the later period (1997-2001) without changes in low turnover bone disease. These data showed a high prevalence of hyperparathyroidism and aluminum-related low turnover bone disease, with no significant changes between the two time-periods analyzed here.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12778854

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  4 in total

Review 1.  New options for the management of hyperparathyroidism after renal transplantation.

Authors:  Walter Guillermo Douthat; Carlos Raul Chiurchiu; Pablo Ulises Massari
Journal:  World J Transplant       Date:  2012-06-24

2.  Aluminium and lead abnormalities in children on haemodialysis: relationship with some medications.

Authors:  Manal F Elshamaa; Samar Sabry; Inas Mokhtar; Gamila S El-Saaid; Mona Raafat; Dalia A Abd-El Haleem
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

3.  Use of percutaneous ethanol injection therapy for recurrent secondary hyperparathyroidism after subtotal parathyroidectomy.

Authors:  Walter G Douthat; Gabriela Cardozo; Gabriela Garay; Santiago Orozco; Carlos Chiurchiu; Jorge de la Fuente; Javier de Arteaga; Pablo U Massari
Journal:  Int J Nephrol       Date:  2011-06-04

4.  Renal osteodystrophy and clinical outcomes: data from the Brazilian Registry of Bone Biopsies - REBRABO.

Authors:  Cinthia Esbrile Moraes Carbonara; Luciene Machado Dos Reis; Kélcia Rosana da Silva Quadros; Noemi Angelica Vieira Roza; Rafael Sano; Aluizio Barbosa Carvalho; Vanda Jorgetti; Rodrigo Bueno de Oliveira
Journal:  J Bras Nefrol       Date:  2020-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.